4.6 Article

Suppression of Regulatory T Cells by IL-12p40 Homodimer via Nitric Oxide

期刊

JOURNAL OF IMMUNOLOGY
卷 183, 期 3, 页码 2045-2058

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0800276

关键词

-

资金

  1. National Institutes of Health [NS39940, NS48923]

向作者/读者索取更多资源

Regulatory T cells (Tregs) play a pivotal role in the maintenance of homeostasis between immune response and immune tolerance. The transcription factor Foxp3 and the surface protein CD25 are the two key molecules characterizing Tregs. In autoimmune and various other chronic inflammatory diseases, the expression of Foxp3 is severely down-regulated. However, the molecular mechanism underlying the down-regulation of Foxp3 is not understood yet. Because the IL-12p40 homodimer (p40(2)) is markedly up-regulated in response to various inflammatory stimuli, the present study was undertaken to explore the role of p40(2) in the regulation of Foxp3 in naive mouse splenocytes. IL-12p40(2) dose-dependently inhibited the expression of Foxp3 and CD25, but not CD4. Interestingly, this inhibition was absent in splenocytes of IL-12R beta 1(-/-), but not IL-12R beta 2(-/-), mice. Moreover, suppression of Foxp3 in wild-type and IL-12R beta 2(-/-) splenocytes was accompanied by production of NO. Consistently, L-N-6 -(1-iminoethyl)lysine hydrochloride, an inhibitor of inducible NO synthase (iNOS), and PTIO, a scavenger of NO, restored the expression of Foxp3 and CD25 in p40(2)-stimulated splenocytes, and p40(2) was unable to down-regulate Foxp3 and CD25 in splenocytes from iNOS(-/-) mice. Furthermore, NO, but not p40(2), was able to inhibit Foxp3 in purified CD4(+)CD25(+) T cells in the absence of iNOS-expressing cells. Hence, our results clearly demonstrate that p40(2) induces NO production via IL-12R beta 1 and that NO subsequently suppresses Tregs in naive mouse splenocytes. This study, therefore, delineates an unprecedented biological function of p40(2) in the regulation of Foxp3 via IL-12R beta 1-mediated NO production. The Journal of Immunology, 2009, 183: 2045-2058.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据